These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 5787869)

  • 1. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
    Schoenfeld RI; Seiden LS
    J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-methyltyrosine: effects on fixed ratio schedules of reinforcement.
    Schoenfeld R; Seiden LS
    J Pharm Pharmacol; 1967 Nov; 19(11):771-2. PubMed ID: 4383702
    [No Abstract]   [Full Text] [Related]  

  • 3. Catecholamines and operant response rates in albino rats.
    Will B; Maurissen J; Ropartz P
    Psychopharmacol Commun; 1976; 2(3):219-29. PubMed ID: 996277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operant behavior and catecholamine-containing neurons: prolonged increase in lever-pressing after 6-hydroxydopamine.
    Schoenfeld RI; Uretsky NJ
    Eur J Pharmacol; 1972 Dec; 20(3):357-62. PubMed ID: 4643457
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM; Babbini M; Khalsa HJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract]   [Full Text] [Related]  

  • 6. Catecholamines and drug-behavior interactions.
    Seiden LS; MacPhail RC; Oglesby MW
    Fed Proc; 1975 Aug; 34(9):1823-31. PubMed ID: 1097267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of electrically-rewarded behavior by interference with monoamine synthesis.
    Black WC; Cooper BR
    Physiol Behav; 1970 Dec; 5(12):1405-9. PubMed ID: 4400321
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 11. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greater lowering of brain and adrenal catecholamines in group-housed than in individually-housed mice administered DL-alpha-methyltyrosine.
    Welch BL; Welch AS
    J Pharm Pharmacol; 1968 Mar; 20(3):244-6. PubMed ID: 4385059
    [No Abstract]   [Full Text] [Related]  

  • 13. Norepinephrine and dopamine in the developing chick brain.
    Kobayashi K; Eiduson S
    Dev Psychobiol; 1970; 3(1):13-34. PubMed ID: 4146802
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of alpha-methyltyrosine and disulfiram on inhibitory function of the caudate nucleus and the catecholamine concentration in the cat brain.
    Arushanyan EB; Stolyarov GV; Tolpyshev BA
    Bull Exp Biol Med; 1974 Aug; 77(2):139-42. PubMed ID: 4433917
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulus-dependent antagonism of the alpha-methyltyrosine-induced lowering of brain catecholamines by (+)-amphetamine in intact mice.
    Welch BL; Welch AS
    J Pharm Pharmacol; 1967 Dec; 19(12):841-3. PubMed ID: 4384230
    [No Abstract]   [Full Text] [Related]  

  • 16. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
    Bloom FE; Aghajanian GK
    J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary-adrenal activity and depletion of brain catecholamines after -methyl-p-tyrosine administration.
    Kaplanski J; Dorst W; Smelik PG
    Eur J Pharmacol; 1972 Nov; 20(2):238-40. PubMed ID: 4651212
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.